By Fineline Cube 
Germany-based Siemens Healthineers AG (ETR: SHL) released its financial report for the second quarter of fiscal 2025, ending March 31, 2025. The report highlights an excellent equipment book-to-bill ratio of 1.14 and comparable revenue growth of 6.8% to EUR 5.909 billion (USD 6.7 billion).
Business Segment Performance
- Imaging: Comparable revenues increased by 8.7% to EUR 3.281 billion (USD 3.7 billion), with an adjusted EBIT margin of 22.4%.
- Diagnostics: Revenues grew by 1.0% to EUR 1.122 billion (USD 1.27 billion), with an adjusted EBIT margin of 6.3%.
- Varian: Revenue expanded by 12.5% to EUR 1.041 billion (USD 1.18 billion), with an adjusted EBIT margin of 13.2%, primarily due to a high equipment revenue share.
- Advanced Therapies: Revenue increased by 3.7% to EUR 553 million (USD 627 million), with an adjusted EBIT margin of 18.5%.
Overall Adjusted EBIT Margin
The overall adjusted EBIT margin was 16.6%, above the prior-year quarter.
Outlook for Fiscal Year 2025
Siemens Healthineers expects comparable revenue growth of between 5% and 6% for fiscal year 2025 compared to fiscal year 2024. Adjusted basic earnings per share (EPS) are projected to range from EUR 2.20 to EUR 2.50, influenced by geopolitical developments, particularly trade barriers and increased tariffs in various countries.-Fineline Info & Tech